Charles River Laboratories International Inc
F:RV6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charles River Laboratories International Inc
F:RV6
|
US |
|
M
|
MacroAsia Corp
XPHS:MAC
|
PH |
|
inTest Corp
F:IN9
|
US |
|
N
|
Nippon Sheet Glass Co Ltd
F:NI9
|
JP |
|
Apollo Commercial Real Estate Finance Inc
NYSE:ARI
|
US |
|
F
|
Ford Motor Co
XHAM:FMC1
|
US |
|
C
|
Carrefour SA
F:CAR
|
FR |
|
G
|
Galderma Group AG
SIX:GALD
|
CH |
|
S
|
Sparebank 1 SR Bank ASA
SWB:B4M1
|
NO |
|
M
|
Morgan Stanley
DUS:DWD
|
US |
Wall St Price Targets
RV6 Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for
RV6 is 197.84 EUR with a low forecast of 131.05 EUR and a high forecast of 252.26 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV6's stock price target?
Price Target
197.84
EUR
According to Wall Street analysts, the average 1-year price target for
RV6 is 197.84 EUR with a low forecast of 131.05 EUR and a high forecast of 252.26 EUR.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Charles River Laboratories International Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 21%.